Fujifilm

Digital X-ray Market Worth $6.6 billion | MarketsandMarkets™

Retrieved on: 
목요일, 5월 9, 2024
Conditional sentence, Shimadzu, Cancer, Injury, Canon, Investment, Carestream Health, Hospital, Osteoarthritis, GE HealthCare, Siemens Healthineers, Research, Fracture, Digital, Algorithm, Incidence, Acquisition, Fujifilm, Google Images, Diagnosis, Ageing, US FDA, Growth, Prevalence, Market development, Medical imaging

The new digital segment accounted for the largest share of the digital X-ray market by system in 2023.

Key Points: 
  • The new digital segment accounted for the largest share of the digital X-ray market by system in 2023.
  • Based on system, the digital X-ray market is segmented into retrofit and new digital x-ray systems.
  • Digital X-ray Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall digital X-ray market and the subsegments.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital X-ray market.

Digital X-ray Market Worth $6.6 billion | MarketsandMarkets™

Retrieved on: 
목요일, 5월 9, 2024
Conditional sentence, Shimadzu, Cancer, Injury, Canon, Investment, Carestream Health, Hospital, Osteoarthritis, GE HealthCare, Siemens Healthineers, Research, Fracture, Digital, Algorithm, Incidence, Acquisition, Fujifilm, Google Images, Diagnosis, Ageing, US FDA, Growth, Prevalence, Market development, Medical imaging

The new digital segment accounted for the largest share of the digital X-ray market by system in 2023.

Key Points: 
  • The new digital segment accounted for the largest share of the digital X-ray market by system in 2023.
  • Based on system, the digital X-ray market is segmented into retrofit and new digital x-ray systems.
  • Digital X-ray Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall digital X-ray market and the subsegments.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital X-ray market.

Fujifilm Introduces First-of-its-Kind Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal Myectomy

Retrieved on: 
금요일, 4월 26, 2024
FDA, Cardiothoracic surgery, AATS, TTE, Tech, Ventricular septal defect, Heart, Cleveland Clinic, Facial muscles, MD, Doctor of Philosophy, NYU, FACS, Indocyanine green, Cardiology, Fujifilm, OPIE, TEE, Division, Medical imaging

Lexington, MA,, April 26, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced the launch of its first-of-kind OPIE Transducer for on-pump intracardiac echocardiography (OPIE) for septal myectomy.

Key Points: 
  • Lexington, MA,, April 26, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced the launch of its first-of-kind OPIE Transducer for on-pump intracardiac echocardiography (OPIE) for septal myectomy.
  • However, with OPIE, a thin transducer is passed into the heart during the myectomy where images of the patient’s septal thickness can be seen in real-time.
  • A study featuring Fujifilm’s OPIE Transducer highlights that the system provides established imaging to aid in septal myectomy procedures compared to TEE and transthoracic echocardiogram (TTE).
  • Real-time measurements of the interventricular septal thickness are crucial during septal myectomy to avoid creating a ventricular septal defect while resecting enough myocardium.

Fujifilm and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals

Retrieved on: 
목요일, 4월 25, 2024
FDA, USP, Inflammation, Bacteria, Death, LPS, Lipopolysaccharide, Patient, LAL, Limulus amebocyte lysate, Gram-negative bacteria, Fujifilm, Fever

Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that the companies have entered into a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.

Key Points: 
  • Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that the companies have entered into a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
  • Per the terms of the agreement, Predictive Oncology will utilize its novel EndoPrep™ sample treatment technology (EndoPrep), together with Fujifilm’s PYROSTAR™ bacterial endotoxin detection reagent (PYROSTAR), to detect residual endotoxins more accurately in biopharmaceuticals by eliminating protein interference from the drug product in the detection assay.
  • The Limulus Amebocyte Lysate (LAL) test is recognized by the U.S. Pharmacopeia (USP) for determining endotoxin levels in many biopharmaceuticals.
  • *Compared to traditional industry standards of utilizing heat-treatment or dilution to remove the interference of high protein.

inriver Highlights Customer Success at PIMpoint Americas 2024

Retrieved on: 
목요일, 4월 25, 2024
Organization, PIM, Ecosystem, AI, Dollar, Pandora, Partnership, Growth, Information management, Michelin, Partner, Microsoft, Digital, SAP, Fujifilm

CHICAGO, April 25, 2024 (GLOBE NEWSWIRE) -- inriver , the leading software company powering the entire product journey with revenue-driving product information management (PIM) across every customer touchpoint, today showcased exceptional customers and partners and announced industry award winners at PIMpoint Americas 2024.

Key Points: 
  • CHICAGO, April 25, 2024 (GLOBE NEWSWIRE) -- inriver , the leading software company powering the entire product journey with revenue-driving product information management (PIM) across every customer touchpoint, today showcased exceptional customers and partners and announced industry award winners at PIMpoint Americas 2024.
  • Joining inriver are customer and partner showcases led by leading brands such as Yamaha , Pandora , Michelin , Prysmian , SAP , Microsoft and many more.
  • These brands represent world-class PIM users that work with inriver to create, enrich and syndicate product information across a variety of channels and marketplaces.
  • In addition to this week’s PIMpoint Americas event, inriver will bring together more leaders in Malmö, Sweden, for PIMpoint Europe on May 15 and 16.

Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina

Retrieved on: 
목요일, 4월 11, 2024
Nitrogen oxide, Fujifilm Diosynth Biotechnologies, Solar energy, Monoclonal antibody, Town, Water, Carbon, Growth, CDMO, Environment, Life, Certification, LEED, Bioreactor, Patient, Gold, Fujifilm, Spacecraft, Renewable energy

TOKYO, April 11, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Corporation today announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO* Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion.

Key Points: 
  • TOKYO, April 11, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Corporation today announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO* Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion.
  • The expansion adds significant large-scale production capacity to FUJIFILM Diosynth Biotechnologies’ global network through its United States and Europe manufacturing hubs.
  • The investment will generate an additional 680 jobs by 2031, also bringing the total number of new, highly skilled local jobs to 1400 in Holly Springs.
  • Over the course of the 12-year term of this grant, the project is estimated to grow the state’s economy by $4.7 billion.

Fujifilm to Debut New Products for Broadcast, Cinema, and Digital Content Creators at NAB 2024

Retrieved on: 
목요일, 4월 4, 2024
Instrument, Super 35, Fujifilm X series, NAB, Steadicam, Central Hall, Fujifilm, Lens, Sony, National Association, Calendar, NAB Show, Telescopic sight

VALHALLA, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Electronic Imaging and Optical Devices Divisions will debut a variety of new gear and technology at the 2024 National Association of Broadcasters Show (NAB 2024) from April 14 – 17, 2024 in Las Vegas.

Key Points: 
  • VALHALLA, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Electronic Imaging and Optical Devices Divisions will debut a variety of new gear and technology at the 2024 National Association of Broadcasters Show (NAB 2024) from April 14 – 17, 2024 in Las Vegas.
  • Duvo™ 25-1000mm was awarded Best Overall Product in the “CREATE” Category of the 2023 NAB Show “Product of the Year” Awards.
  • “The continual excitement around our products is constantly generating conversations and creating new avenues for customers to explore.
  • For more information about Fujifilm's presence at NAB 2024, click here .

Fujifilm Files Patent Infringement Lawsuit Against Eastman Kodak Company

Retrieved on: 
수요일, 3월 20, 2024
Fujifilm, Patent, Kodak, District court, KODK, Research, Sale, Unified Patent Court, Investment, 3D printing

HANOVER PARK, Ill., March 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division today announced that FUJIFILM Corporation filed a patent infringement lawsuit against Eastman Kodak Company (NYSE: KODK) in the United States District Court for the District of New Jersey.

Key Points: 
  • HANOVER PARK, Ill., March 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division today announced that FUJIFILM Corporation filed a patent infringement lawsuit against Eastman Kodak Company (NYSE: KODK) in the United States District Court for the District of New Jersey.
  • Fujifilm has asserted four patents (U.S. Patent Nos.
  • 10,427,443, 10,525,696, 10,875,346, and 11,294,279) pertaining to various aspects of processless lithographic printing plate technologies, including method and apparatus claims.
  • “We will enforce and protect our innovation and intellectual property rights in the United States and around the world when we believe others infringe unfairly.”
    Separately in October 2023 and December 2023 respectively, Eastman Kodak’s European subsidiaries, Kodak GmbH, Kodak Graphic Communications GmbH, and Kodak Holding GmbH, were sued by FUJIFILM Corporation for infringement of the related European counterparts of the US patents-in-suit in the Unified Patent Court and in Germany.

Fujifilm Demonstrates Commitment to and Investment in Education at the 2024 Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition

Retrieved on: 
목요일, 3월 7, 2024
Cloud, Radiology, Architecture, Enterprise imaging, Artificial intelligence, AI, Education, MD, HIMSS, Cardiology, Health, Fujifilm, Organization, URG, VNA, Environment, Miller, AWS, PACS, Synapse

Fujifilm’s KLAS award-winning and government-validated Synapse® Enterprise Imaging solutions will be presented and available for demonstration in booth 4461.

Key Points: 
  • Fujifilm’s KLAS award-winning and government-validated Synapse® Enterprise Imaging solutions will be presented and available for demonstration in booth 4461.
  • These solutions include 7x Enterprise PACS, AI Orchestrator, VNA, EIS/RIS, 3D Advanced Visualization, Enterprise Imaging Analytics, Cloud Services, and Pathology PACS.
  • “Our vision has been laser focused on delivering the best possible enterprise imaging solution to meet our customers' growing needs.
  • “Our team looks forward to demonstrating how Fujifilm’s Synapse Enterprise Imaging portfolio is orchestrating AI and further innovating diagnostic workflows with AI results.

Fujifilm Announces Availability of FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens: Wide, Light, and Long

Retrieved on: 
목요일, 3월 7, 2024
NAB Show, Lens, Fujifilm, Fujinon, Steadicam, NAB, Telescopic sight

VALHALLA, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Optical Devices Division announces the availability of its new FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens (”Duvo 24-300mm“).

Key Points: 
  • VALHALLA, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Optical Devices Division announces the availability of its new FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens (”Duvo 24-300mm“).
  • Fujifilm expects to begin shipping initial orders of Duvo 24-300mm to customers at the end of March, 2024.
  • This versatile portable lens can be used with a tripod, shoulder-mounted with a Steadicam [2] , or for high-angle shooting, using a crane.
  • Complementing the previously released FUJINON Duvo™ HZK25-1000mm F2.8-F5.0 PL Mount Cinema Box Lens (“Duvo 25-1000mm”) — Fujifilm’s first Duvo Series lens — Duvo 24-300mm delivers 12.5x zoom, covering the frequently used 24-300mm focal range.